Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors
- PMID: 1958902
Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors
Abstract
Patients transplanted with marrow from an HLA-phenotypically identical unrelated donor have a much higher risk of acute graft-versus-host disease (GVHD) than patients transplanted from an HLA-genotypically identical sibling. Much of this increased risk may be due to disparity for antigens encoded by genes within the MHC. Although the development of molecular genetic methods for HLA-typing may enable better matching between unrelated donor/recipient pairs, the extent to which GVHD risk might be decreased remains uncertain because disparity for minor histocompatibility antigens encoded by genes outside the MHC also causes GVHD. By application of fundamental population genetics, it can be demonstrated that the disparity for minor histocompatibility antigens is substantially greater between unrelated individuals than between family members. These findings imply that even with improved HLA-matching, unrelated marrow transplantation will carry more risk of GVHD than transplantation from a related donor.
Similar articles
-
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7. Biol Blood Marrow Transplant. 1997. PMID: 9209736
-
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.Dan Med Bull. 2002 May;49(2):89-108. Dan Med Bull. 2002. PMID: 12064093 Review.
-
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.N Engl J Med. 1996 Feb 1;334(5):281-5. doi: 10.1056/NEJM199602013340501. N Engl J Med. 1996. PMID: 8532022
-
Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.Nat Med. 1999 Jul;5(7):839-42. doi: 10.1038/10563. Nat Med. 1999. PMID: 10395333
-
Histocompatibility and bone marrow transplantation (BMT).Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(3-4):445-50. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989. PMID: 2480287 Review.
Cited by
-
Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.J Clin Invest. 1996 Jul 1;98(1):100-7. doi: 10.1172/JCI118753. J Clin Invest. 1996. PMID: 8690780 Free PMC article.
-
Immune recognition, response, and regulation: how T lymphocytes do it.Immunol Res. 2001;23(2-3):215-28. doi: 10.1385/IR:23:2-3:215. Immunol Res. 2001. PMID: 11444386 Review.
-
Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.Curr Opin Hematol. 2010 Nov;17(6):483-92. doi: 10.1097/MOH.0b013e32833eb770. Curr Opin Hematol. 2010. PMID: 20827186 Free PMC article. Review.
-
Two types of human TCR differentially regulate reactivity to self and non-self antigens.iScience. 2022 Aug 17;25(9):104968. doi: 10.1016/j.isci.2022.104968. eCollection 2022 Sep 16. iScience. 2022. PMID: 36111255 Free PMC article.
-
Prediction of graft-versus-host disease in humans by donor gene-expression profiling.PLoS Med. 2007 Jan;4(1):e23. doi: 10.1371/journal.pmed.0040023. PLoS Med. 2007. PMID: 17378698 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials